Editors' note: This article discusses one or more penny stocks and/or microcaps. Such stocks are easily manipulated; do your own careful due diligence.
Company: Tibet Rhodiola Pharmaceutical Holding Company
Bloomberg ticker: 600211 SH
Market cap: US$4,139m
Background: Tibet Rhodiola Pharmaceutical Holding Company manufactures and wholesales pharmaceutical products. Its main products include Chinese patent medicine, biological products, and chemical medicine. Tibet Rhodiola Pharmaceutical Holding is headquartered in Lhasa, China.
World Class Benchmarking of Tibet Rhodiola Pharmaceutical Holding
(Click on image to enlarge)
- Profitable Growth rank of 2 was same compared to the prior period’s 2nd rank
- This is World Class performance compared to 410 medium Health Care companies worldwide
- Profitability rank of 1 was better than its Growth rank of 2
- Profitability rank of 1 was up compared to the prior period’s 2nd rank
- This is World Class performance compared to peers
- Growth rank of 2 was up compared to the prior period’s 4th rank
- This is World Class performance compared to peers
Comments
Log in or sign up to join the conversation.